查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1975224

全球病患登记软体市场规模、份额、趋势和成长分析报告（2026-2034年）

Global Patient Registry Software Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 236 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

病患登记软体市场预计将从 2025 年的 14.9 亿美元成长到 2034 年的 35.6 亿美元，2026 年至 2034 年的复合年增长率为 10.17%。

随着医疗机构和研究机构日益重视数据驱动的决策，全球患者登记软体市场正在快速成长。患者登记平台收集和管理与特定疾病、治疗或人群相关的数据，以便更好地监测治疗效果和长期趋势。人们对个人化医疗和人群健康管理的日益关注，正在推动对这些解决方案的需求。

关键成长要素包括慢性病和罕见病患疾病的上升、临床研究活动的扩展以及监管核准中对真实世界数据的需求。各国政府和医疗机构正在投资数位化工具，以改善流行病学追踪和卫生计画评估。基于云端的註册系统进一步提高了可存取性和扩充性。

展望未来，由于先进分析技术、人工智慧以及与电子健康记录（EHR）系统的互通性不断提升，市场预计将显着扩张。製药公司与医疗服务提供者之间合作的加强也将促进市场应用。随着精准医疗的不断发展，病患登记软体将在改进临床研究和患者照护策略方面继续发挥核心作用。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球病患登记软体市场：按类型划分

  • 市场分析、洞察与预测
  • 疾病登记处（心血管疾病登记处、癌症登记处、罕见疾病登记处、气喘登记处、慢性肾臟病登记处及其他登记处）
  • 医疗保健服务登记处
  • 产品註册

第五章 全球病患登记软体市场：依软体类型划分

  • 市场分析、洞察与预测
  • 独立版
  • 融合的

第六章：全球病患登记软体市场：依定价模式

  • 市场分析、洞察与预测
  • 订阅
  • 所有权

第七章 全球病患登记软体市场：依部署模式划分

  • 市场分析、洞察与预测
  • 现场
  • 基于云端的

第八章 全球病患登记软体市场：依资料库

  • 市场分析、洞察与预测
  • 商业的
  • 公共

第九章：全球病患登记软体市场：功能

  • 市场分析、洞察与预测
  • PHM
  • 交换医疗资讯
  • 患者照护管理
  • 护理点
  • 医学研究和临床试验
  • 产品性能评估

第十章 全球病患登记软体市场：依最终用途划分

  • 市场分析、洞察与预测
  • 政府机构和第三方管理机构
  • 医院和诊所
  • 私人保险公司
  • 製药、生技和医疗设备公司
  • 研究中心

第十一章 全球病患登记软体市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 亚太其他地区
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第十二章 竞争格局

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第十三章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Global Vision Technology
    • IQVIA Inc
    • Dacima Software Inc
    • McKesson Corporation
    • OpenText Corporation
    • ImageTrend Inc
    • Evado Clinical
    • IFA Systems AG
    • VersaForm Systems Corporation
    • IBM Corporation
    • Optum Inc
简介目录
Product Code: VMR112112144

The Patient Registry Software Market size is expected to reach USD 3.56 Billion in 2034 from USD 1.49 Billion (2025) growing at a CAGR of 10.17% during 2026-2034.

The Global Patient Registry Software Market is growing rapidly as healthcare providers and research institutions emphasize data-driven decision-making. Patient registry platforms collect and manage data related to specific diseases, treatments, or populations, enabling better monitoring of outcomes and long-term trends. Increasing focus on personalized medicine and population health management is fueling demand for such solutions.

Key growth drivers include the rising prevalence of chronic and rare diseases, expansion of clinical research activities, and the need for real-world evidence in regulatory approvals. Governments and healthcare organizations are investing in digital tools that improve epidemiological tracking and health program evaluation. Cloud-based registry systems are further enhancing accessibility and scalability.

Looking forward, the market is poised for substantial expansion with the integration of advanced analytics, artificial intelligence, and interoperability with EHR systems. Growing collaborations between pharmaceutical companies and healthcare providers will also boost adoption. As precision medicine continues to evolve, patient registry software will remain central to clinical research and improved patient care strategies.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Disease Registry (Cardiovascular Registries, Cancer Registries, Rare Disease Registries, Asthma Registries, Chronic Kidney Disease Registries, Other Registries)
  • Health Service Registry
  • Product Registry

By Software

  • Standalone
  • Integrated

By Pricing Model

  • Subscription
  • Ownership

By Deployment Model

  • On Premise
  • Cloud Based

By Database

  • Commercial
  • Public

By Functionality

  • PHM
  • Health Information Exchange
  • Patient Care Management
  • Point-of-Care
  • Medical Research & Clinical Studies
  • Product Outcome Evaluation

By End Use

  • Government Organizations & Third-Party Administrators
  • Hospitals and Medical Practices
  • Private Payers
  • Pharmaceutical, Biotechnology, and Medical Device Companies
  • Research Centers

COMPANIES PROFILED

  • Global Vision Technology, IQVIA Inc, Dacima Software Inc, McKesson Corporation, OpenText Corporation, ImageTrend Inc, Evado Clinical, IFA Systems AG, VersaForm Systems Corporation, IBM Corporation, Optum Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Disease Registry (Cardiovascular Registries, Cancer Registries, Rare Disease Registries, Asthma Registries, Chronic Kidney Disease Registries, Other Registries) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Health Service Registry Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Product Registry Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY SOFTWARE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Software
  • 5.2. Standalone Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Integrated Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY PRICING MODEL 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Pricing Model
  • 6.2. Subscription Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ownership Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY DEPLOYMENT MODEL 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Deployment Model
  • 7.2. On Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cloud Based Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY DATABASE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast Database
  • 8.2. Commercial Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Public Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY FUNCTIONALITY 2022-2034 (USD MN)

  • 9.1. Market Analysis, Insights and Forecast Functionality
  • 9.2. PHM Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.3. Health Information Exchange Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.4. Patient Care Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.5. Point-of-Care Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.6. Medical Research & Clinical Studies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 9.7. Product Outcome Evaluation Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY END USE 2022-2034 (USD MN)

  • 10.1. Market Analysis, Insights and Forecast End Use
  • 10.2. Government Organizations & Third-Party Administrators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.3. Hospitals and Medical Practices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.4. Private Payers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.5. Pharmaceutical, Biotechnology, and Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 10.6. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 11. GLOBAL PATIENT REGISTRY SOFTWARE MARKET: BY REGION 2022-2034(USD MN)

  • 11.1. Regional Outlook
  • 11.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.2.1 By Type
    • 11.2.2 By Software
    • 11.2.3 By Pricing Model
    • 11.2.4 By Deployment Model
    • 11.2.5 By Database
    • 11.2.6 By Functionality
    • 11.2.7 By End Use
    • 11.2.8 United States
    • 11.2.9 Canada
    • 11.2.10 Mexico
  • 11.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.3.1 By Type
    • 11.3.2 By Software
    • 11.3.3 By Pricing Model
    • 11.3.4 By Deployment Model
    • 11.3.5 By Database
    • 11.3.6 By Functionality
    • 11.3.7 By End Use
    • 11.3.8 United Kingdom
    • 11.3.9 France
    • 11.3.10 Germany
    • 11.3.11 Italy
    • 11.3.12 Russia
    • 11.3.13 Rest Of Europe
  • 11.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.4.1 By Type
    • 11.4.2 By Software
    • 11.4.3 By Pricing Model
    • 11.4.4 By Deployment Model
    • 11.4.5 By Database
    • 11.4.6 By Functionality
    • 11.4.7 By End Use
    • 11.4.8 India
    • 11.4.9 Japan
    • 11.4.10 South Korea
    • 11.4.11 Australia
    • 11.4.12 South East Asia
    • 11.4.13 Rest Of Asia Pacific
  • 11.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.5.1 By Type
    • 11.5.2 By Software
    • 11.5.3 By Pricing Model
    • 11.5.4 By Deployment Model
    • 11.5.5 By Database
    • 11.5.6 By Functionality
    • 11.5.7 By End Use
    • 11.5.8 Brazil
    • 11.5.9 Argentina
    • 11.5.10 Peru
    • 11.5.11 Chile
    • 11.5.12 South East Asia
    • 11.5.13 Rest of Latin America
  • 11.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 11.6.1 By Type
    • 11.6.2 By Software
    • 11.6.3 By Pricing Model
    • 11.6.4 By Deployment Model
    • 11.6.5 By Database
    • 11.6.6 By Functionality
    • 11.6.7 By End Use
    • 11.6.8 Saudi Arabia
    • 11.6.9 UAE
    • 11.6.10 Israel
    • 11.6.11 South Africa
    • 11.6.12 Rest of the Middle East And Africa

Chapter 12. COMPETITIVE LANDSCAPE

  • 12.1. Recent Developments
  • 12.2. Company Categorization
  • 12.3. Supply Chain & Channel Partners (based on availability)
  • 12.4. Market Share & Positioning Analysis (based on availability)
  • 12.5. Vendor Landscape (based on availability)
  • 12.6. Strategy Mapping

Chapter 13. COMPANY PROFILES OF GLOBAL PATIENT REGISTRY SOFTWARE INDUSTRY

  • 13.1. Top Companies Market Share Analysis
  • 13.2. Company Profiles
    • 13.2.1 Global Vision Technology
    • 13.2.2 IQVIA Inc
    • 13.2.3 Dacima Software Inc
    • 13.2.4 McKesson Corporation
    • 13.2.5 OpenText Corporation
    • 13.2.6 ImageTrend Inc
    • 13.2.7 Evado Clinical
    • 13.2.8 IFA Systems AG
    • 13.2.9 VersaForm Systems Corporation
    • 13.2.10 IBM Corporation
    • 13.2.11 Optum Inc